Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0LTI stock hub

LON/0LTI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LTIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LTI

In the news

Latest news · LON/0LTI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.4

P25 12.9P50 16.9P75 23.5

Trailing P/E75.1

P25 15.9P50 22.9P75 35.8

ROE5.2

P25 -54.2P50 2.1P75 13.7

ROIC6.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LTI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	7,900
Employees Change	300%
Employees Change Percent	3.95
Enterprise value	$29.1B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US9418481035
Last refreshed	2026-05-10
Market cap	$25.6B
Price	$345
Price currency	USD
Rev Per Employee	178,531.29x
Sector	Healthcare
Sic	3826
Symbol	lon/0LTI
Website	https://www.waters.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.33%
EV Earnings	85.34x
EV/EBIT	45.08x
EV/EBITDA	31.87x
EV/FCF	145.45x
EV/Sales	10.51x
FCF yield	0.78%
Forward P/E	23.41x
P/B ratio	2.21x
P/E ratio	75.1x
P/S ratio	8.96x
PE Ratio10 Y	73.64x
PE Ratio3 Y	33.54x
PE Ratio5 Y	31.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.31%
EBITDA Margin	32.97%
FCF margin	7%
Gross margin	57.97%
Gross Profit	$1.7B
Gross Profit Growth	23.61%
Gross Profit Growth Q	80.28%
Gross Profit Growth3 Y	8.33%
Gross Profit Growth5 Y	8.42%
Net Income	$340.7M
Net Income Growth	-31.57%
Net Income Growth Years	1%
Net Income Growth3 Y	-13.26%
Net Income Growth5 Y	-6.11%
Pretax Margin	13.89%
Profit Margin	11.93%
Profit Per Employee	$21,291
Profitable Years	14
ROA	3.77
Roa5y	14.31
ROE	5.21
Roe5y	108.6
ROIC	6.4
Roic5y	35.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	2.48%
Cagr3y	5.21%
Cagr5y	2.53%
EPS Growth	-37.49
EPS Growth Years	1
EPS Growth3 Y	-15.72
EPS Growth5 Y	-6.96
FCF Growth	-57.4%
FCF Growth3 Y	-14.89%
FCF Growth5 Y	-17.65%
OCF Growth	-48.66%
OCF Growth10 Y	-3.69%
OCF Growth3 Y	-13.91%
OCF Growth5 Y	-14.59%
Revenue Growth	26.38x
Revenue Growth Q	91.48x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	8.33x
Revenue Growth5 Y	8.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$18.6B
Cash	$350M
Current Assets	$2.7B
Debt	$4B
Debt EBITDA	$4.2
Debt Equity	$0.34
Debt FCF	$19.77
Equity	$11.6B
Interest Coverage	8.33
Liabilities	$7B
Long Term Assets	$15.9B
Net Cash	$-3.6B
Net Cash By Market Cap	$-14.08
Net Debt EBITDA	$3.82
Net Debt Equity	$0.31
Net Debt FCF	$18.02
Tangible Book Value	$-2.1B
Tangible Book Value Per Share	$-25.86
WACC	9.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Inventory Turnover	1.58
Working Capital	$2.8B
Working Capital Turnover	$1.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	2.48%
200-day SMA	335.4
3Y total return	16.45%
50-day SMA	311.4
50-day SMA vs 200-day SMA	50under200
5Y total return	13.3%
All Time High	425.8
All Time High Change	-18.9%
All Time High Date	2021-09-09
All Time Low	164.2
All Time Low Change	110.32%
All Time Low Date	2020-03-16
ATR	17.02
Beta	1.14
Ch YTD	-9.53
High	355
High52	415.5
High52 Date	2025-11-26
High52ch	-16.89%
Low	340
Low52	270
Low52 Date	2026-05-04
Low52ch	27.91%
Ma50ch	10.9%
Price vs 200-day SMA	2.95%
RSI	63.84
RSI Monthly	52.51
RSI Weekly	54.08
Sharpe ratio	0.17x
Sortino ratio	0.39
Total Return	-9.55%
Tr YTD	-9.53
Tr1m	13.4%
Tr1w	12.61%
Tr3m	-9.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$665.8M
Operating Income Growth	3.98
Operating Income Growth Q	-2.47
Operating Income Growth3 Y	1.02
Operating Income Growth5 Y	2.84
Operating margin	23.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,023,538%
Net Borrowing	-161,373,080
Shares Insiders	0.08%
Shares Institutions	77.84%
Shares Qo Q	37.44%
Shares Yo Y	9.55%
Short Ratio	3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$153.6M
Average Volume	332.15x
Bv Per Share	141.1
CAPEX	$-95.3M
Ch1m	13.4
Ch1w	12.61
Ch1y	2.48
Ch3m	-9.58
Ch3y	16.45
Ch5y	13.3
Ch6m	-5.77
Change	0.58%
Change From Open	-0.48
Close	343.4
Days Gap	1.06
Depreciation Amortization	267,172,938.8
Dollar Volume	19,339.2
Earnings Date	2026-08-04
EBIT	$665.8M
EBITDA	$941.8M
EPS	$5.22
F Score	3
FCF	$199.9M
FCF EV Yield	0.69x
Financing CF	-210,020,210
Fiscal Year End	December
Founded	1,958
Goodwill	6,834,149,938
Graham Number	127.20081
Graham Upside	-63.17
Income Tax	$56.3M
Investing CF	-23,678,367
Is Primary Listing	0
Last Earnings Date	2026-02-09
Last Report Date	2026-04-04
Lynch Fair Value	$22.99
Lynch Upside	-93.34
Ma150	348.9
Ma150ch	-1.03%
Ma20	322.6
Ma20ch	7.06%
Net CF	59,456,164
Next Earnings Date	2026-08-04
Open	347
P FCF Ratio	128
P OCF Ratio	86.68
Position In Range	35.58
Ppne	1,114,941,280
Price Date	2026-05-08
Price EBITDA	$27.17
Relative Volume	0.17x
Revenue	2,856,500,634x
SBC By Revenue	1.62x
Share Based Comp	46,311,955
Tax By Revenue	1.97x
Tax Rate	14.17%
Tr6m	-5.77%
Volume	56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LTI pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LTI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LTI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.8%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LTI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.8

Neutral momentum band

Price vs 200-day MA

+3.0%

50/200-day relationship not available

Beta (5Y)

1.14

Moves roughly with the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LTI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LTI stock rating?

lon/0LTI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LTI analysis?

The full report lives at /stocks/lon/0LTI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LTI?

The latest report frames lon/0LTI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LTI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.